OTHER INVESTMENT - RELATED PARTY	9 Months Ended
Sep. 30, 2020
Investments, All Other Investments [Abstract]
OTHER INVESTMENT - RELATED PARTY	NOTE 5 – OTHER INVESTMENT - RELATED PARTY On September 13, 2019, the Company entered into a Definitive Acquisition Agreement (the “DAA”) with Egg Health Hub, Inc. (“EGG”), a related party. Pursuant to the terms of the DAA, EGG and the Company agreed to commence the negotiation and preparation of a definitive share exchange agreement (the “Definitive Agreement”) pursuant to which EGG would exchange all of its issued and outstanding shares of common stock for shares of the Company’s common stock on a one-for-one basis which, upon the closing of the transactions contemplated by the Definitive Agreement, would constitute 70,000,000 shares of EGG’s issued and outstanding common stock. EGG has no employees, does not currently conduct operations and has no financial assets and liabilities. EGG is a brand new model for healthcare and wellness that brings together top physicians and wellness professionals into co-practicing communities with shared access to a full-stack technology platform – scheduling, billing, client acquisition, and telemedicine – and flexible access to office space designed to optimize both the physician and client experience. This model creates a compelling new option for re-tenanting traditional shopping centers and mixed-use space. On July 27, 2020, the Company and MediXall Group, Inc. (“MediXall”), a related party, entered into an assignment of the DAA. As a result of the COVID-19 Outbreak, the Company determined that the original opportunity that existed with EGG was no longer practical in the short-term. The Company and MediXall believed, however, that the EGG concept remained a viable concept on a virtual basis, and MediXall possesses the infrastructure and willingness to pursue this opportunity. In exchange for 1,000,000 shares of MediXall’s common stock, the Company assigned its interest in the DAA to MediXall. The receipt of MediXall’s common stock was accounted for as a transaction between entities with common ownership that lacks economic substance. As such, the receipt of MediXall’s common stock was recorded at its historic carrying amount of $1,000. This investment is accounted for in accordance with GAAP, using the cost-method. At September 30, 2020 there were no identified events or changes in circumstances that may have a significant adverse effect on the carrying value of the investment.

OTHER INVESTMENT - RELATED PARTY

9 Months Ended

Sep. 30, 2020

Investments, All Other Investments [Abstract]

NOTE 5 – OTHER INVESTMENT - RELATED PARTY

On September 13, 2019, the Company entered into a Definitive Acquisition Agreement (the “DAA”) with Egg Health Hub, Inc. (“EGG”), a related party. Pursuant to the terms of the DAA, EGG and the Company agreed to commence the negotiation and preparation of a definitive share exchange agreement (the “Definitive Agreement”) pursuant to which EGG would exchange all of its issued and outstanding shares of common stock for shares of the Company’s common stock on a one-for-one basis which, upon the closing of the transactions contemplated by the Definitive Agreement, would constitute 70,000,000 shares of EGG’s issued and outstanding common stock. EGG has no employees, does not currently conduct operations and has no financial assets and liabilities.

EGG is a brand new model for healthcare and wellness that brings together top physicians and wellness professionals into co-practicing communities with shared access to a full-stack technology platform – scheduling, billing, client acquisition, and telemedicine – and flexible access to office space designed to optimize both the physician and client experience. This model creates a compelling new option for re-tenanting traditional shopping centers and mixed-use space.

On July 27, 2020, the Company and MediXall Group, Inc. (“MediXall”), a related party, entered into an assignment of the DAA. As a result of the COVID-19 Outbreak, the Company determined that the original opportunity that existed with EGG was no longer practical in the short-term. The Company and MediXall believed, however, that the EGG concept remained a viable concept on a virtual basis, and MediXall possesses the infrastructure and willingness to pursue this opportunity. In exchange for 1,000,000 shares of MediXall’s common stock, the Company assigned its interest in the DAA to MediXall. The receipt of MediXall’s common stock was accounted for as a transaction between entities with common ownership that lacks economic substance. As such, the receipt of MediXall’s common stock was recorded at its historic carrying amount of $1,000. This investment is accounted for in accordance with GAAP, using the cost-method. At September 30, 2020 there were no identified events or changes in circumstances that may have a significant adverse effect on the carrying value of the investment.

TurnKey Capital, Inc. 10-Q